Levocarnitine
Product Images NDC 50383-172

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levocarnitine (NDC 50383-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levocarnitine Structural Formula (C8a590a7 628b 45c5 Ac2c 24214a69eaa6 01)

Levocarnitine Structural Formula (C8a590a7 628b 45c5 Ac2c 24214a69eaa6 01)
Chemical structure diagram of levocarnitine depicting its molecular arrangement, including a quaternary ammonium group, hydroxyl group, and carboxylate group, consistent with the active ingredient levocarnitine.*
FDA Label Image

Carton (Image 01)

FDA Label Image

Image 02

Image 02
Packaging label for Levocarnitine Tablets USP 330 mg by Akorn. The label indicates 90 tablets per bottle, prescription only, with dosing instructions referring to the package insert. It includes the NDC 50383-172-90 and mentions storage at controlled room temperature. Distributed by Hi-Tech Pharmacal Co., Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.